54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
14:33 UTC
|
ORA
Ormat Technologies
|
◎ Target | Noah Kaye ★★☆☆☆ #2546 | Outperform | $144.00→ $141.00-2.1% |
|
Aug 07
14:33 UTC
|
NVMI
Nova
|
◎ Target | Charles Shi ★☆☆☆☆ #3079 | Buy | $640.00→ $570.00-10.9% |
|
Aug 07
14:33 UTC
|
NTRA
Natera
|
◎ Target | Brandon Couillard ★★★★☆ #462 | Equal Weight | $220.00→ $284.00+29.1% |
|
Aug 07
14:33 UTC
|
NET
Cloudflare
|
◎ Target | Mike Cikos ★★★★★ #98 | Buy | $280.00→ $380.00+35.7% |
|
Aug 07
14:33 UTC
|
NET
Cloudflare
|
◎ Target | Param Singh ★★★☆☆ #1084 | Outperform | $330.00→ $380.00+15.2% |
|
Aug 07
14:33 UTC
|
NET
Cloudflare
|
◎ Target | Jackson Ader ★★★★☆ #972 | Overweight | $300.00→ $375.00+25.0% |
|
Aug 07
14:33 UTC
|
MTRN
Materion
|
◎ Target | Samuel McKinney ★★★★☆ #871 | Overweight | $237.00→ $306.00+29.1% |
|
Aug 07
14:33 UTC
|
MRVI
Maravai LifeSciences
|
◎ Target | Evan Stampler not yet tracked | Overweight | $5.50→ $6.50+18.2% |
|
Aug 07
14:33 UTC
|
MNST
Monster Beverage
|
◎ Target | Peter Grom ★★★★★ #270 | Neutral | $104.00→ $105.00+1.0% |
|
Aug 07
14:33 UTC
|
ITT
ITT
|
◎ Target | Jeffrey Hammond ★★☆☆☆ #2757 | Overweight | $250.00→ $263.00+5.2% |
|
Aug 07
14:33 UTC
|
IRTC
iRhythm Technologies
|
◎ Target | Nathan Treybeck ★★★☆☆ #1247 | Overweight | $180.00→ $168.00-6.7% |
|
Aug 07
14:33 UTC
|
IRTC
iRhythm Technologies
|
◎ Target | David Saxon ★★★★★ #312 | Buy | $255.00→ $192.00-24.7% |
|
Aug 07
14:33 UTC
|
INSM
Insmed
|
◎ Target | Benjamin Burnett ★★★☆☆ #1802 | Overweight | $161.00→ $169.00+5.0% |
|
Aug 07
14:33 UTC
|
HRZN
Horizon Technology Finance
|
◎ Target | Mitchel Penn ★★☆☆☆ #2813 | Market Perform | $6.00→ $5.00-16.7% |
|
Aug 07
14:33 UTC
|
HALO
Halozyme Therapeutics
|
◎ Target | Mohit Bansal ★★★☆☆ #1220 | Equal Weight | $75.00→ $95.00+26.7% |
|
Aug 07
14:33 UTC
|
GRDN
Guardian Pharmacy Services
|
◎ Target | Michael Wiederhorn ★★★★★ #200 | Outperform | $43.00→ $49.00+14.0% |
|
Aug 07
14:33 UTC
|
GMED
Globus Medical
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Overweight | $103.00→ $99.00-3.9% |
|
Aug 07
14:33 UTC
|
GLUE
Monte Rosa Therapeutics
|
◎ Target | Derek Archila ★★☆☆☆ #2360 | Overweight | $29.00→ $27.00-6.9% |
|
Aug 07
14:33 UTC
|
GENI
Genius Sports
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $10.00→ $12.00+20.0% |
|
Aug 07
14:33 UTC
|
GENI
Genius Sports
|
◎ Target | Jed Kelly ★★★☆☆ #1589 | Outperform | $10.00→ $12.00+20.0% |
|
Aug 07
14:33 UTC
|
GDRX
GoodRx
|
◎ Target | Stan Berenshteyn ★★★★★ #317 | Overweight | $3.50→ $5.00+42.9% |
|
Aug 07
14:33 UTC
|
FWONK
Liberty Media Corporation - Liberty Formula One Series C
|
◎ Target | Steven Cahill not yet tracked | Equal Weight | $97.00→ $105.00+8.2% |
|
Aug 07
14:33 UTC
|
FSLR
First Solar
|
◎ Target | Praneeth Satish ★★★☆☆ #2254 | Overweight | $300.00→ $313.00+4.3% |
|
Aug 07
14:33 UTC
|
FROG
JFrog
|
◎ Target | Jason Celino ★★★★☆ #371 | Overweight | $89.00→ $114.00+28.1% |
|
Aug 07
14:33 UTC
|
FROG
JFrog
|
◎ Target | Ittai Kidron ★★★★☆ #474 | Outperform | $105.00→ $115.00+9.5% |
|
Aug 07
14:33 UTC
|
FLL
Full House Resorts
|
◎ Target | Jordan Bender ★★☆☆☆ #2884 | Market Outperform | $4.00→ $3.00-25.0% |
|
Aug 07
14:33 UTC
|
FIGS
FIGS
|
◎ Target | Ashley Owens ★★★★☆ #689 | Overweight | $19.00→ $20.00+5.3% |
|
Aug 07
14:33 UTC
|
ENOV
Enovis
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Overweight | $40.00→ $39.00-2.5% |
|
Aug 07
14:33 UTC
|
DDOG
Datadog
|
◎ Target | Mike Cikos ★★★★★ #98 | Buy | $260.00→ $300.00+15.4% |
|
Aug 07
14:33 UTC
|
DAN
Dana
|
◎ Target | Colin Langan ★★☆☆☆ #2484 | Equal Weight | $33.00→ $28.00-15.2% |
|
Aug 07
14:33 UTC
|
CYTK
Cytokinetics
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $105.00→ $110.00+4.8% |
|
Aug 07
14:33 UTC
|
CRBP
Corbus Pharmaceuticals
|
◎ Target | Jeff Jones ★☆☆☆☆ #3012 | Outperform | $52.00→ $48.00-7.7% |
|
Aug 07
14:33 UTC
|
COP
ConocoPhillips
|
◎ Target | Sam Margolin ★★★★☆ #754 | Overweight | $183.00→ $189.00+3.3% |
|
Aug 07
14:33 UTC
|
CGNX
Cognex
|
◎ Target | James Ricchiuti ★★☆☆☆ #2610 | Buy | $75.00→ $80.00+6.7% |
|
Aug 07
14:33 UTC
|
CCOI
Cogent Communications
|
◎ Target | Brandon Nispel ★★☆☆☆ #2503 | Overweight | $25.00→ $15.00-40.0% |
|
Aug 07
14:33 UTC
|
CART
Maplebear
|
◎ Target | Jason Helfstein ★★☆☆☆ #2576 | Outperform | $60.00→ $65.00+8.3% |
|
Aug 07
14:33 UTC
|
CARG
CarGurus
|
◎ Target | Chris Pierce ★☆☆☆☆ #3145 | Buy | $43.00→ $44.00+2.3% |
|
Aug 07
14:33 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Leland Gershell ★☆☆☆☆ #3010 | Outperform | $95.00→ $97.00+2.1% |
|
Aug 07
14:33 UTC
|
BETR
Better Home & Finance
|
◎ Target | Kyle Peterson ★★★☆☆ #1696 | Buy | $35.00→ $25.00-28.6% |
|
Aug 07
14:33 UTC
|
BDX
Becton, Dickinson and Company
|
◎ Target | Lawrence Biegelsen not yet tracked | Equal Weight | $161.00→ $170.00+5.6% |
|
Aug 07
14:33 UTC
|
AVNT
Avient
|
◎ Target | Abigail Eberts not yet tracked | Overweight | $47.00→ $48.00+2.1% |
|
Aug 07
14:33 UTC
|
ARDX
Ardelyx
|
◎ Target | Julian Harrison ★★☆☆☆ #2874 | Buy | $17.00→ $14.00-17.6% |
|
Aug 07
14:33 UTC
|
AMPH
Amphastar Pharmaceuticals
|
◎ Target | Benjamin Burnett ★★★☆☆ #1802 | Equal Weight | $19.00→ $20.00+5.3% |
|
Aug 07
14:33 UTC
|
AGBK
AGI
|
◎ Target | Rayna Kumar ★★★☆☆ #1444 | Outperform | $10.00→ $9.00-10.0% |
|
Aug 07
14:33 UTC
|
ABNB
Airbnb
|
◎ Target | Jed Kelly ★★★☆☆ #1589 | Outperform | $180.00→ $190.00+5.6% |
|
Aug 07
14:33 UTC
|
ABNB
Airbnb
|
◎ Target | Matthew Condon ★★☆☆☆ #2541 | Market Outperform | $170.00→ $190.00+11.8% |
|
Aug 07
14:33 UTC
|
TTD
Trade Desk
|
↓ Downgrade | Michael Morris ★★★☆☆ #2031 | Buy→ Neutral | $12.00 |
|
Aug 07
14:33 UTC
|
CZWI
Citizens Community Bancorp
|
↓ Downgrade | firm only | Neutral | |
|
Aug 07
14:33 UTC
|
VRT
Vertiv
|
↑ Upgrade | firm only | Hold→ Buy | $381.00 |
|
Aug 07
14:33 UTC
|
RXO
RXO
|
↑ Upgrade | firm only | Market Perform→ Mkt Outperform | $30.00 |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.